Tenet Healthcare Corporation $THC Stock Position Reduced by Wellington Management Group LLP

Wellington Management Group LLP lowered its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 91.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 207,419 shares of the company’s stock after selling 2,137,500 shares during the period. Wellington Management Group LLP’s holdings in Tenet Healthcare were worth $38,804,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. PeakShares LLC lifted its holdings in shares of Tenet Healthcare by 3.3% during the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after buying an additional 54 shares during the last quarter. Sanctuary Advisors LLC increased its position in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after buying an additional 57 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock valued at $1,616,000 after buying an additional 58 shares in the last quarter. Applied Finance Capital Management LLC boosted its stake in shares of Tenet Healthcare by 3.8% during the 1st quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock worth $310,000 after acquiring an additional 60 shares in the last quarter. Finally, Syon Capital LLC increased its holdings in shares of Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock valued at $249,000 after acquiring an additional 63 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

Shares of THC stock opened at $265.28 on Friday. The company has a market capitalization of $21.36 billion, a P/E ratio of 10.23, a P/E/G ratio of 1.00 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The stock has a 50 day moving average of $238.07 and a two-hundred day moving average of $211.23.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same period in the prior year, the company posted $4.02 earnings per share. Tenet Healthcare’s revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts expect that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Christopher Lynch sold 3,837 shares of Tenet Healthcare stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total transaction of $934,079.28. Following the sale, the director directly owned 9,568 shares of the company’s stock, valued at approximately $2,329,233.92. The trade was a 28.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Saumya Sutaria sold 50,000 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the completion of the sale, the chief executive officer directly owned 483,564 shares in the company, valued at approximately $134,774,122.44. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 109,189 shares of company stock valued at $29,264,109. Corporate insiders own 0.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on THC shares. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, August 23rd. Barclays raised their target price on Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a report on Friday, July 24th. Zacks Research upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Buy” and a consensus price target of $273.00.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.